J.P.Morgan Investment Banking Pitch Book slide image

J.P.Morgan Investment Banking Pitch Book

APPENDIX Rob Kindler Managing Director, New York Global Head of Mergers & Acquisitions Rob was born in New York in 1954. He received a B.A. from Colgate University in 1976 and a J.D. from New York University School of Law in 1980. He is on the Board of Trustees of Colgate University, the Board of Directors of March of Dimes (NY Div), and the Board of Directors of the Knight-Bagehot Fellowship Program at Columbia University Graduate School of Journalism. Prior to joining JP Morgan, Rob was a senior partner at the law firm of Cravath, Swaine & Moore, where he specialized in mergers and acquisitions for over 20 years. ■ Cendant in its proposed separation into four companies ■ Nextel in its $42 billion merger with Sprint ■ Comcast in its $72 billion successful unsolicited bid for AT&T Broadband ■ CenturyTel in its successful defense against a $9 billion unsolicited offer by Alltel ■ DreamWorks in its $4 billion spin-off of DreamWorks Animation ■ Johnson Controls in its $3.2 billion acquisition of York International ■ MCI in its $9 billion sale to Verizon ■ GenCorp in its successful defense against a $1.3 billion bid by steel Partners ■ Grey Global in its $1.5 billion acquisition by WPP Group ■AMLI Properties in its proposed $2 billion sale to Prime Property Fund ■ Summit Properties in its $2 billion acquisition by Camden ■ Pechiney in its hostile defense and its $7.1 billion acquisition by Alcan ■ A private equity group in the $7 billion acquisition of the Qwest directories business ■ PCCW in the $1.0 billion investment by China Netcom ■ Avaya in its $635 million acquisition of Tenovis GmbH ■ Citizens Communications in its recapitalization ■ Panamerican Beverages in its $3.5 billion acquisition by Coca-Cola Femsa ■ Lycos in its $12.5 billion merger with Terra Networks ■ Corning in the $850 million sale of its precision lens business to 3M ■ Houghton Mifflin in its $2.2 billion acquisition by Vivendi ■ Bristol-Myers Squibb in its $6 billion spin-off of its Zimmer surgical products business JPMorgan KERZNER INTERNATIONAL 29
View entire presentation